Results 151 to 160 of about 576,409 (261)

Serum C-X-C motif chemokine ligand 9, interleukin 8, and interleukin 22 as key biomarkers in pediatric inflammatory bowel disease. [PDF]

World J Gastroenterol
Eindor-Abarbanel A, Tsai K, Sandhu A, Vallance B, Jacobson K.   +4 more
europepmc   +1 more source

An Injectable ROS‐Responsive Nanozyme Hydrogel Regulates the Uterine Microenvironment to Prevent Intrauterine Adhesions

Advanced Science, EarlyView.
The injectable CeTA@GPP hydrogel is administered via intrauterine injection, forming a protective barrier. In the high ROS inflammatory microenvironment of injured endometrium, boronate ester cleavage triggers responsive CeTA release and local enrichment.
Peixian Cheng, Jian Song, Yuxin Li, Ming Chen, Zeshen Liang, Binyao Qiu, Xuemin Liu, Xuetao Shi, Yong Fan   +8 more
wiley   +1 more source

Cytokines and Madness: A Unifying Hypothesis of Schizophrenia Involving Interleukin-22. [PDF]

Int J Mol Sci
Sfera A, Thomas KA, Anton J.
europepmc   +1 more source

Local immune cell contributions to fracture healing in aged individuals - A novel role for interleukin 22. [PDF]

Exp Mol Med, 2022
Bucher CH, Berkmann JC, Burkhardt LM, Paschke C, Schlundt C, Lang A, Wolter A, Damerau A, Geissler S, Volk HD, Duda GN, Schmidt-Bleek K.   +11 more
europepmc   +1 more source

D4F‐Functionalized Ceria Nanozyme‐CasRx Platform Suppresses STING and Reprograms the Renal Immune Niche in Acute Kidney Injury

Advanced Science, EarlyView.
D4F‐functionalized ceria nanozyme–CasRx nanoparticles preferentially target renal macrophages through SR‐B1‐mediated uptake in ischemia–reperfusion injury. Ceria scavenges excessive ROS, while CasRx silences STING signaling, shifting macrophages toward a less inflammatory, pro‐resolving state and increasing the proportion of regulatory T cells.
Weibo Chen, Ming Li, Xuesheng Wang, Jiajia Sun, Ziyuan Zhang, Yongfeng Gong, Benkang Shi, Nengwang Yu, Yunuo Mao, Shengtian Zhao, Xiulin Zhang, Liqiang Guo   +11 more
wiley   +1 more source

Intestinal interleukin-22 enhances GLP-1 production via the STAT3 pathway to improve glucose homeostasis during high-fat diet induced obesity in a study with male mice. [PDF]

Nat Commun
Kim CW, Ahn JH, Lee BR, Kim HM, Han Y, Jeong JH, Cho J, Jeong H, Kim DJ, Kim SE, Kim JK, Lee YB, Kim SM, Yoo HH, Lee EH, Seo SR, Ha KB, Lee ES, Kweon MN, Kim HP, Chang SY, Chung CH, Ko HJ.   +22 more
europepmc   +1 more source

Interleukin-22: a potential therapeutic target in atherosclerosis. [PDF]

Mol Med, 2021
Luo JW, Hu Y, Liu J, Yang H, Huang P.
europepmc   +1 more source

Interleukin‐1α Mediates Pancreatic Fibroblast Activation, Regulates Immune Cell Recruitment and Fibrosis in Acute and Chronic Pancreatitis

Advanced Science, EarlyView.
During pancreatitis, IL‐1α is released from necrotic acinar cells. In response to IL‐1α, pancreatic fibroblasts release chemokines and cytokines that regulate the recruitment of immune cells to the damaged organ. Furthermore, IL‐1α primes fibroblasts, resulting in increased tissue fibrosis during chronic pancreatitis.
Hala Mazloum, Shenja Buchholz, Hanna Schifter, Sabine Ameling, Leif Steil, Ben Lewin Becker, Elke Hammer, Georg Homuth, Uwe Völker, Barbara M. Bröker, Lukas Zierke, Frank Ulrich Weiss, Juliane Glaubitz, Matthias Sendler   +13 more
wiley   +1 more source

Interleukin-22 functions to alleviate hypoxia-induced intestinal inflammation by modulating pro- and anti-inflammatory factors in <i>Pelteobagrus fulvidraco</i>. [PDF]

Zool Res
Huan HQ, Ding YB, Qian ZA, Ji J, Ning XH, Yin SW, Zhang K.   +6 more
europepmc   +1 more source

Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. [PDF]

Nat Commun, 2022
Pavlidis P, Tsakmaki A, Pantazi E, Li K, Cozzetto D, Digby-Bell J, Yang F, Lo JW, Alberts E, Sa ACC, Niazi U, Friedman J, Long AK, Ding Y, Carey CD, Lamb C, Saqi M, Madgwick M, Gul L, Treveil A, Korcsmaros T, Macdonald TT, Lord GM, Bewick G, Powell N.   +24 more
europepmc   +1 more source